Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Keymed Biosciences (02162.HK) Reports Strong Interim 2025 Results with Accelerated Commercialization and Robust R&D Momentum
2025-08-27 14:02
iNtRON Bio, files Two Patent Applications for IMPA™ Platform-Based Gene Editing Technology
2025-08-26 21:00
Fosun Pharma Announces 2025 Interim Results
2025-08-26 20:42
Brightonix Imaging's High-Performance 'PHAROS' PET Receives FDA Clearance
2025-08-26 19:00
Peijia Medical Announces 2025 Interim Results
2025-08-25 20:00
Akeso Reports Phase 3 Trials Show Positive Results: Gumokimab (IL-17) for Ankylosing Spondylitis and Manfidokimab (IL-4Rα) for Atopic Dermatitis Achieve Primary Endpoints
2025-08-25 13:46
Harbour BioMed Appoints Yajie Li as Chief Medical Officer
2025-08-25 09:00
Innovent Biologics Announces U.S. FDA IND Approval for the First Global MRCT Phase 3 Study (MarsLight-11) of IBI363 (PD-1/IL-2α-bias) in Squamous Non-Small Cell Lung Cancer
2025-08-25 08:00
Heartbeats Launches Digital Wellness Platform Led by World-Renowned Heart Specialist Dr. Hosen Kiat
2025-08-22 13:22
BioDlink's Bevacizumab Approved for Market Launch in Indonesia, Marking Fourth Consecutive Emerging Market Authorization
2025-08-21 20:00
SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health
2025-08-21 20:00
FDA clearance of Salix® Coronary Plaque module
2025-08-21 19:43
Zylox-Tonbridge Announces 2025 Interim Results: Strong Revenue Growth with Net Profit Surging Over 76% Year-over-Year
2025-08-20 21:41
Cell therapy is promising in treating psychiatric disorders, such as depression. -- A proof-of-principle study published in "Cell Stem Cell" by the laboratory of Dr. Chen, founder of UniXell Biotech, suggests this.
2025-08-20 20:49
First Patient Dosed in Pivotal Phase III Trial of Cadonilimab (PD-1/CTLA-4) for Perioperative Treatment of Resectable Gastric Cancer
2025-08-20 16:11
Mabwell's CDH17-targeting ADC 7MW4911 Receives IND Clearance from FDA
2025-08-19 22:00
WuXi Biologics Reports Solid 2025 Interim Results
2025-08-19 20:35
Tigermed Receives MSCI ESG AAA Rating
2025-08-19 11:15
Datasea Achieves Breakthrough in Acoustic Technology, Accelerating Billion-Dollar Commercialization in Healthcare
2025-08-18 21:30
LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company
2025-08-18 20:00